MACCHINI, MARINA
MACCHINI, MARINA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment
2012 M Macchini; G Brandi; S Tavolari; T Guarnieri; M Di Marco; P Paterini; F De Rosa; S Di Girolamo; S Vecchiarelli; A Papi; G Biasco
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
2014 Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;Biasco G
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques.
2014 Silvia Vecchiarelli;Mariacristina Di Marco; Annalisa Astolfi; Elisa Grassi; Valentina Indio; Marina Macchini; Claudio Ricci; Riccardo Casadei; Marielda D'Ambra; Carla Serra; Giorgio Ercolani; Donatella Santini; Antonietta D'Errico; Antonio Daniele Pinna; Francesco Minni; Guido Biasco
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array
2015 Di Marco, Mariacristina; Astolfi, Annalisa; Grassi, Elisa; Vecchiarelli, Silvia; Macchini, Marina; Indio, Valentina; Casadei, Riccardo; Ricci, Claudio; D'Ambra, Marielda; Taffurelli, Giovanni; Serra, Carla; Ercolani, Giorgio; Santini, Donatella; D'Errico, Antonia; Pinna, Antonio Daniele; Minni, Francesco; Durante, Sandra; Martella, Laura Raffaella; Biasco, Guido
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases
2011 Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Barbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G.
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
2021 Orsi G.; Di Marco M.; Cavaliere A.; Niger M.; Bozzarelli S.; Giordano G.; Noventa S.; Rapposelli I.G.; Garajova I.; Tortora G.; Rodriquenz M.G.; Bittoni A.; Penzo E.; De Lorenzo S.; Peretti U.; Paratore C.; Bernardini I.; Mosconi S.; Spallanzani A.; Macchini M.; Tamburini E.; Bencardino K.; Giommoni E.; Scartozzi M.; Forti L.; Valente M.M.; Militello A.M.; Cascinu S.; Milella M.; Reni M.
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS
2011 Vecchiarelli S; Macchini M; Di Marco M; Pezzilli R; Fabbri D; Imbrogno A; Casadei R; Melzi d’Eril G; Sina S; Biasco G
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs?
2017 Bernhard W. Renz, Barbara Mayer, Marina Macchini, Timothy C. Wang, Riccardo Casadei, Mariacristina di Marco, Axel Kleespies, Jens Werner
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer
2011 Monari F; D'Ambra M; Ricci C; Buscemi S; Calculli L; Pezzilli R; Santini D; Di Marco MC; Macchini M; Casadei R; Minni F
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer
2013 Silvia Vecchiarelli; Marina Macchini; Elisa Grassi; Fabio Ferroni; Federica Ciccarese; Lucia Calculli; Claudio Ricci; Riccardo Casadei; Raffaele Pezzilli; Guido Biasco; Mariacristina Di Marco
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer
2012 S. Vecchiarelli; M. Macchini; C. Ricci; M. D'Ambra; R. Casadei; L. Calculli; M. Di Marco;
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer.
2012 Macchini M.; Ricci C.; Vecchiarelli S.; D’Ambra M.; Casadei R.; Calculli L.; Pezzilli R.; Grassi E.; Minni F.; Biasco G.; Di Marco M.
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007))
2018 Renz, Bernhard W.; Takahashi, Ryota; Tanaka, Takayuki; Macchini, Marina; Hayakawa, Yoku; Dantes, Zahra; Maurer, H. Carlo; Chen, Xiaowei; Jiang, Zhengyu; Westphalen, C. Benedikt; Ilmer, Matthias; Valenti, Giovanni; Mohanta, Sarajo K.; Habenicht, Andreas J.R.; Middelhoff, Moritz; Chu, Timothy; Nagar, Karan; Tailor, Yagnesh; Casadei, Riccardo; Di Marco, Mariacristina; Kleespies, Axel; Friedman, Richard A.; Remotti, Helen; Reichert, Maximilian; Worthley, Daniel L.; Neumann, Jens; Werner, Jens; Iuga, Alina C.; Olive, Kenneth P.; Wang, Timothy C.
Follow-up del cancro del pancreas esocrino
2015 Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia
GemOx and Ovarian Pancreatic Cancer Metastasis (PC)
2010 Pallotti MC; Vecchiarelli S; Macchini M; Di Marco M; D’Ambra M; Ferroni F; Poli F; Calculli L; Minni F; Casadei R; Santini D; Biasco G
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE
2008 M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco
Gemox in combination witherlotinib (E) in pancreatic cancer (PC).
2008 R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
2021 U. Peretti, A. Cavaliere, M. Niger, G. Tortora, M. C. Di Marco, M. G. Rodriquenz, F. Centonze, I. G. Rapposelli, G. Giordano, F. De Vita, L. Stuppia, A. Avallone, M. Ratti, C. Paratore, L. G. Forti, G. Orsi, M. M. Valente, M. Gaule, M. Macchini, P. Carrera, S. Calzavara, M. Simbolo, D. Melisi, F. De Braud, L. Salvatore, S. De Lorenzo, C. Chiarazzo, M. Falconi, S. Cascinu, M. Milella, M. Reni
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment | M Macchini; G Brandi; S Tavolari; T Guarnieri; M Di Marco; P Paterini; F De Rosa; S Di Girolamo; ...S Vecchiarelli; A Papi; G Biasco | 2012-01-01 | PANCREATOLOGY | Academic Press (Elsevier) | 4.02 Riassunto (Abstract) | - |
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. | Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;B...iasco G | 2014-01-01 | PANCREAS | - | 1.01 Articolo in rivista | - |
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. | Silvia Vecchiarelli;Mariacristina Di Marco; Annalisa Astolfi; Elisa Grassi; Valentina Indio; Mari...na Macchini; Claudio Ricci; Riccardo Casadei; Marielda D'Ambra; Carla Serra; Giorgio Ercolani; Donatella Santini; Antonietta D'Errico; Antonio Daniele Pinna; Francesco Minni; Guido Biasco | 2014-01-01 | PANCREATOLOGY | - | 4.03 Poster | - |
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array | Di Marco, Mariacristina; Astolfi, Annalisa; Grassi, Elisa; Vecchiarelli, Silvia; Macchini, Marina...; Indio, Valentina; Casadei, Riccardo; Ricci, Claudio; D'Ambra, Marielda; Taffurelli, Giovanni; Serra, Carla; Ercolani, Giorgio; Santini, Donatella; D'Errico, Antonia; Pinna, Antonio Daniele; Minni, Francesco; Durante, Sandra; Martella, Laura Raffaella; Biasco, Guido | 2015-01-01 | MOLECULAR MEDICINE REPORTS | - | 1.01 Articolo in rivista | - |
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases |
Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Ba...rbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G. |
2011-01-01 | ONCOLOGY LETTERS | - | 1.01 Articolo in rivista | - |
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey | Orsi G.; Di Marco M.; Cavaliere A.; Niger M.; Bozzarelli S.; Giordano G.; Noventa S.; Rapposelli ...I.G.; Garajova I.; Tortora G.; Rodriquenz M.G.; Bittoni A.; Penzo E.; De Lorenzo S.; Peretti U.; Paratore C.; Bernardini I.; Mosconi S.; Spallanzani A.; Macchini M.; Tamburini E.; Bencardino K.; Giommoni E.; Scartozzi M.; Forti L.; Valente M.M.; Militello A.M.; Cascinu S.; Milella M.; Reni M. | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | articolo 2021 Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv)- a multicenter survey.pdf |
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS |
Vecchiarelli S; Macchini M; Di Marco M; Pezzilli R; Fabbri D; Imbrogno A; Casadei R; Melzi d’Eril... G; Sina S; Biasco G |
2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.02 Riassunto (Abstract) | - |
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? | Bernhard W. Renz, Barbara Mayer, Marina Macchini, Timothy C. Wang, Riccardo Casadei, Mariacristin...a di Marco, Axel Kleespies, Jens Werner | 2017-01-01 | PANCREATOLOGY | - | 1.06 Abstract in rivista | - |
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer | Monari F; D'Ambra M; Ricci C; Buscemi S; Calculli L; Pezzilli R; Santini D; Di Marco MC; Macchini... M; Casadei R; Minni F | 2011-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer | Silvia Vecchiarelli; Marina Macchini; Elisa Grassi; Fabio Ferroni; Federica Ciccarese; Lucia Calc...ulli; Claudio Ricci; Riccardo Casadei; Raffaele Pezzilli; Guido Biasco; Mariacristina Di Marco | 2013-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.01 Contributo in Atti di convegno | - |
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer | S. Vecchiarelli; M. Macchini; C. Ricci; M. D'Ambra; R. Casadei; L. Calculli; M. Di Marco; | 2012-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. | Macchini M.; Ricci C.; Vecchiarelli S.; D’Ambra M.; Casadei R.; Calculli L.; Pezzilli R.; Grassi ...E.; Minni F.; Biasco G.; Di Marco M. | 2012-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.02 Riassunto (Abstract) | - |
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007)) | Renz, Bernhard W.; Takahashi, Ryota; Tanaka, Takayuki; Macchini, Marina; Hayakawa, Yoku; Dantes, ...Zahra; Maurer, H. Carlo; Chen, Xiaowei; Jiang, Zhengyu; Westphalen, C. Benedikt; Ilmer, Matthias; Valenti, Giovanni; Mohanta, Sarajo K.; Habenicht, Andreas J.R.; Middelhoff, Moritz; Chu, Timothy; Nagar, Karan; Tailor, Yagnesh; Casadei, Riccardo; Di Marco, Mariacristina; Kleespies, Axel; Friedman, Richard A.; Remotti, Helen; Reichert, Maximilian; Worthley, Daniel L.; Neumann, Jens; Werner, Jens; Iuga, Alina C.; Olive, Kenneth P.; Wang, Timothy C. | 2018-01-01 | CANCER CELL | - | 1.01 Articolo in rivista | - |
Follow-up del cancro del pancreas esocrino | Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall...'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia | 2015-01-01 | - | Bologna University Press | 2.01 Capitolo / saggio in libro | - |
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) | Pallotti MC; Vecchiarelli S; Macchini M; Di Marco M; D’Ambra M; Ferroni F; Poli F; Calculli L; Mi...nni F; Casadei R; Santini D; Biasco G | 2010-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE | M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). | R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco | 2008-01-01 | JOP. JOURNAL OF THE PANCREAS | s.n | 4.02 Riassunto (Abstract) | - |
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort | U. Peretti, A. Cavaliere, M. Niger, G. Tortora, M. C. Di Marco, M. G. Rodriquenz, F. Centonze, I.... G. Rapposelli, G. Giordano, F. De Vita, L. Stuppia, A. Avallone, M. Ratti, C. Paratore, L. G. Forti, G. Orsi, M. M. Valente, M. Gaule, M. Macchini, P. Carrera, S. Calzavara, M. Simbolo, D. Melisi, F. De Braud, L. Salvatore, S. De Lorenzo, C. Chiarazzo, M. Falconi, S. Cascinu, M. Milella, M. Reni | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | Articolo Di marco 2021 ESMO open.pdf |